Proteogenomics enhances the identification of therapeutic vulnerabilities in breast cancer – Medical Xpress

Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity of breast cancer. With this approach, the researchers were able to propose more precise diagnostics for known treatment targets, identify new tumor susceptibilities for translation into treatments for aggressive tumors and implicate new mechanisms involved in breast cancer treatment resistance. The…

Click here to view the original article.